fda semaglutide shortage status january 2025 cracks down on weight-loss drug alternatives as thousands sickened in Maryland Medscape | The FDA has

You see the same care team, visit after visit

Use in the morning or early afternoon as directed

doi: 10.1136/gutjnl-2014-307264 172 StaudacherHMScholzMLomerMCRalphFSIrvingPMLindsayJOet al

peak during dose escalation and fade within days to two weeks after each dose increase

This is risky for several reasons: Wrong patient selection, such as people with pancreatitis, gallstones, or severe kidney disease using them without screening Rapid, unsupervised dose escalation No monitoring of kidney, liver, pancreatic, or eye status Complications seen with unsupervised use include pancreatitis, dehydration-induced acute kidney injury (especially in hot Indian summers with vomiting or diarrhoea), and even diabetic ketoacidosis in susceptible individuals

People who take both medications should take special care to stay hydrated, eat slowly, and avoid large meals